Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme-Reference-Cited by-同舟云学术

Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme

Published:2022-04 Issue:4 Volume:21 Page:342-354
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Mead Simon,Khalili-Shirazi Azadeh,Potter Caroline,Mok Tzehow,Nihat Akin,Hyare Harpreet,Canning Stephanie,Schmidt Christian,Campbell Tracy,Darwent Lee,Muirhead Nicola,Ebsworth Nicolette,Hextall Patrick,Wakeling Madeleine,Linehan Jacqueline,Libri Vincenzo,Williams Bryan,Jaunmuktane Zane,Brandner Sebastian,Rudge Peter,Collinge John

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference37 articles.

1. Prion diseases of humans and animals: their causes and molecular basis;Collinge;Annu Rev Neurosci,2001

2. Genetic factors in mammalian prion diseases;Mead;Annu Rev Genet,2019

3. Kuru in the 21st century—an acquired human prion disease with very long incubation periods;Collinge;Lancet,2006

4. Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial;Collinge;Lancet Neurol,2009

5. Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease;Geschwind;Neurology,2013

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. α-Synuclein strain propagation is independent of cellular prion protein expression in a transgenic synucleinopathy mouse model;PLOS Pathogens;2024-09-12

2. Genetic insights into drug targets for sporadic Creutzfeldt-Jakob disease: Integrative multi-omics analysis;Neurobiology of Disease;2024-09

3. Single-domain antibodies and aptamers drive new opportunities for neurodegenerative disease research;Frontiers in Immunology;2024-08-22

4. Perspectives on CRISPR Genome Editing to Prevent Prion Diseases in High-Risk Individuals;Biomedicines;2024-08-01

5. Adaptation of the protein misfolding cyclic amplification (PMCA) technique for the screening of anti‐prion compounds;The FASEB Journal;2024-07-28